Skip to main page content
访问密钥 NCBI首页 MyNCBI Homepage Main Content Main Navigation

搜索页

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Number of Results
1979 1
1992 1
1995 1
2007 3
2009 1
2010年 1
2014 2
2015 1
2016 1
2017 1
2018 1
2021 3
2022 6
文本可用性
Article attribute
Article type
发布日期

搜索结果

22results
Results by year
Filters applied:Clear all
第1页
Selexipag for the treatment of chronic thromboembolic pulmonary hypertension.
ogo t,Shimokawahara h, Kinoshita H, Sakao S, Abe K, Matoba S, Motoki H, Takama N, Ako J, Ikeda Y, Joho S, Maki H, Saeki T, Sugano T, Tsujino I, Yoshioka K, Shiota N, Tanaka S, Yamamoto C, Tanabe N, Tatsumi K; Study Group. Ogo T等。在作者中:shimokawahara h Eur Respir J. 2022 Jul 7;60(1):2101694. doi: 10.1183/13993003.01694-2021. Print 2022 Jul. Eur Respir J. 2022. PMID:34824052 免费PMC文章。 临床试验。
Response by Kawakami et al to Letter Regarding Article, "Novel Angiographic Classification of Each Vascular Lesion in Chronic Thromboembolic Pulmonary Hypertension Based on Selective Angiogram and Results of Balloon Pulmonary Angioplasty".
Kawakami T,Ogawa A,Miyaji K,Mizoguchi H,Shimokawahara h,Naito T,Oka T,Yunoki K,Munemasa M,Matsubara H. Kawakami T, et al. Among authors:shimokawahara h Circ Cardiovasc间隔。2017Feb;10(2):e004962. doi: 10.1161/CIRCINTERVENTIONS.117.004962. Circ Cardiovasc间隔。2017。 PMID:28193682 没有抽象可用。
肺idiop复苏的压力athic, hereditary and drug and toxin-induced pulmonary arterial hypertension: Determinants and clinical impact.
Badagliacca R,Vizza CD,Lang I,Sadushi-Kolici R,Papa S,Manzi G,Filomena D,Ogawa A,Shimokawahara h, Matsubara H. Badagliacca R等。在作者中:shimokawahara h Vascul Pharmacol。2022年9月1日:107099。doi:10.1016/j.vph.2022.107099。在线印刷。 Vascul Pharmacol。2022。 PMID:36058492
22results